Differences in the multiple step process of inhibition of neurotransmitter release induced by tetanus toxin and botulinum neurotoxins type A and B at Aplysia synapses

Neuroscience

Volumn 70, Issue 2, 1996, Pages 567-576

  Poulain, B ^a,d   De Paiva, A ^b   Deloye, F ^e   Doussau, F ^d   Tauc, L ^e   Weller, U ^c   Dolly, J O ^b  

^a LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d CNRS   (France)

^e NONE

Author keywords

SNAP 25; VAMP synaptobrevin

Indexed keywords

BOTULINUM TOXIN; TETANUS TOXIN;

ANIMAL TISSUE; APLYSIA; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

ANIMAL; APLYSIA; CHOLINERGIC FIBERS; DOSE-RESPONSE RELATIONSHIP, DRUG; NEUROTOXINS; NEUROTRANSMITTERS; SUPPORT, NON-U.S. GOV'T; SYNAPSES; TETANUS TOXIN;

EID: 0029655650     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00336-3     Document Type: Article

References (43)

1. Ahnert-Hilger G. and Weller U. (1993) Comparison of the intracellular effects of clostridial neurotoxins on exocytosis from streptolysin 0-permeabilized rat pheochromocytoma (PC 12) and bovine adrenal chromaffin cells. Neuroscience 53, 547-552.
2. Beise J., Hahnen J., Andersen-Beckh B. and Dreyer F. (1994) Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule. Naunyn-Schmiedeberg's Arch. Pharmac. 349, 66-73.
3. 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J. Cell Biol. 103, 521-534.
4. 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J. Cell Biol. 103, 535-544.
5. Dolly J. O. (1992) Peptide toxins that alter neurotransmitter release. In Selective Neurotoxicity (eds Herken H. and Hucho F.), Handbook of Experimental Pharmacology 102, 681-717.
6. Dolly J. O., de Paiva A., Foran P., Lawrence G., Daniels-Holgater P. and Ashton A. C. (1994) Probing the process of transmitter release with botulinum and tetanus neurotoxins. Seminars Neurosci. 6, 149-158.
7. Donovan J. J. and Middlebrook J. L. (1986) Ion-conducting channels produced by botulinum toxin in planar lipid membranes. Biochemistry 25, 2872-2876.
8. Dreyer F. and Schmitt A. (1983) Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature. Pflügers Arch. 399, 228-234.
9. Edelmann L., Hanson P. I., Chapman E. R. and Jahn R. (1995) Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. Eur. molec. Biol. Org. J. 14, 224-231.
10. Foran P., Shone C. C. and Dolly J. O. (1994) Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane proteins and various sized. Biochemistry 33, 15,365-15,374.
11. Gansel M., Penner R. and Dreyer F. (1987) Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals. Pflügers Arch. 409, 533-539.
12. Habermann E., Dreyer F. and Bigalke H. (1980) Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn-Schmiedeberg's Arch. Pharmac. 311, 33-40.
13. Hayashi T., McMahon H., Yamasaki S., Binz T., Hata Y., Südhof T. C. and Niemann H. (1994) Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. Eur. molec. Biol. Org. J. 13, 5051-5061.
14. Maisey E. A., Wadsworth J. D. F., Poulain B., Shone C., Melling J., Gibbs P., Taue L. and Dolly J. O. (1988) Involvement of the constituent chains of botulinum neurotoxins, types A and B, in their blockade of neurotransmitter release. Eur. J. Biochem. 177, 683-691.
15. McMahon H. T. and Südhof T. C. (1995) Synaptic core complex of synaptobrevin, syntaxin, and SNAP25 forms high affinity α-SNAP binding site. J. biol. Chem. 270, 2213-2217.
16. Menestrina G., Forti F. and Gambale G. (1989) Interaction of tetanus toxin with lipid vesicles. Effects of pH, surface charges, and transmembrane potential on the kinetics of channel formation. Biophys. J. 55, 393-405.
17. Mochida S., Poulain B., Weller U., Habermann E. and Taue L. (1989) Light chain of tetanus toxin intracellularly inhibits acetylcholine release at neuro-neuronal synapses, and its internalization is mediated by heavy chain. Fedn Eur. biochem. Socs Lett. 253, 47-51.
18. Montecucco C., Papini E. and Schiavo G. (1994) Bacterial protein toxins penetrate cells via a four-step mechanism. Fedn Eur. biochem. Socs Lett. 346, 92-98.
19. Montecucco C. and Schiavo G. (1995) Structure and function of tetanus and botulinum neurotoxins. Q. Rev. Biophys. (in press).
20. Niemann H., Blasi J. and Jahn R. (1994) Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol. 4, 179-185.
21. Parton R. G., Ockleford C. D. and Critchley D. R. (1987) A study of the mechanism of internalisation of tetanus toxin by primary mouse spinal cord cultures. J. Neurochem. 49, 1057-1058.
22. Pellegrini L., O'Connor V. and Betz H. (1994) Fusion complex formation protects synaptobrevin against proteolysis by tetanus toxin light chain. Fedn Eur. biochem. Socs Lett. 353, 319-323.
23. Penner R., Neher E. and Dreyer F. (1986) Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells. Nature 324, 76-78.
24. Poulain B., De Paiva A., Dolly J. O., Weller U. and Taue L. (1992) Differences in temperature dependence of botulinum and tetanus uptake in Aplysia. Neurosci. Lett. 139, 289-292.
25. Poulain B., Mochida S., Weller U., Högy B., Habermann E., Wadsworth J. D. F., Dolly J. O., Shone C. C. and Taue L. (1991) Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neuro-transmitter release in Aplysia. J. biol. Chem. 266, 9580-9585.
26. Poulain B., Taue L., Maisey E. A., Wadsworth J. D. F., Mohan M. and Dolly J. O. (1988) Neurotransmitter release is blocked intracellularly by Botulinum neurotoxin and this requires uptake of both its polypeptides by a process mediated by the larger chain. Proc. natn. Acad. Sci. U.S.A. 85, 4090-4093.
27. Poulain B., Wadsworth J. D. F., Shone C. C., Mochida S., Lande S., Melling J., Dolly J. O. and Taue L. (1989) Multiple domains of botulinum neurotoxin contribute to its inhibition of neuro-transmitter release. J. biol. Chem. 264, 21,928-21,933.
28. Rothman J. E. (1994) Mechanism of intracellular protein transport. Nature 372, 55-63.
29. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B. R. and Montecucco C. (1992) Tetanus toxin and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832-835.
30. Schmitt A., Dreyer F. and John C. (1981) At least three sequential steps are involved in the tetanus toxin-induced block of neuromuscular transmission. Naunyn-Schmiedeberg's Arch. Pharmac. 317, 326-330.
31. Simpson L. L. (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J. Pharmac. exp. Ther. 212, 16-21.
32. Simpson L. L. (1982) The interaction between aminoquinolines and presynaptically acting neurotoxins. J. Pharmac. exp. Ther. 222, 43-48.
33. Simpson L. L. (1983) Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J. Pharmac. exp. Ther. 225, 546-552.
34. Simpson L. L. (1986) Molecular pharmacology of botulinum toxin and tetanus toxin. A. Rev. Pharmac. Toxic. 26, 427-453.
35. Simpson L. L. (1988) Use of pharmacologic antagonists to deduce commonalities of biological activity among clostridial neurotoxins. J. Pharmac. exp. Ther. 245, 867-872.
36. Simpson L. L. and DasGupta B. R. (1982) Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships. J. Pharmac. exp. Ther. 224, 135-140.
37. Stöckel K., Schwab M. and Thoenen H. (1975) Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res. 99, 1-16.
38. Washbourne P., Schiavo G. and Montecucco C. (1995) Vesicle-associated membrane protein-2 (synaptobrevin-2) forms a complex with synaptophysin. Biochem. J. 305, 721-724.
39. Weller U., Aktories M.-E., Gansel M. and Dreyer F. (1991) Cooperative action of the light chain of tetanus and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates. Neurosci. Lett. 122, 132-134.
40. Weller U., Dauzenroth M.-E., Meyer zu Heringdorf D. and Habermann E. (1989) Chains and fragments of tetanus toxin. Separation, reassociation and pharmacological properties. Eur. J. Biochem. 182, 649-656.
41. Weller U., Taylor C. F. and Habermann E. (1986) Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon 24, 1055-1063.
42. Wellhöner H. H. (1992) Tetanus and botulinum neurotoxins. In Selective Neurotoxicity (eds Herken H. and Hucho F.), Handbook of Experimental Pharmacology 102, 357-417.
43. Williamson L. C. and Neale E. A. (1994) Bafilomycin Al inhibits the action of tetanus toxin in spinal cord neurons in cell culture. J. Neurochem. 63, 2342-2345.